Publication:
Oral bisphosphonate therapy for vitamin D intoxication of the infant

dc.contributor.authorBEREKET, ABDULLAH
dc.contributor.authorGÜRAN, TÜLAY
dc.contributor.authorsBereket, A; Erdogan, T
dc.date.accessioned2022-03-12T17:16:18Z
dc.date.accessioned2026-01-10T18:46:21Z
dc.date.available2022-03-12T17:16:18Z
dc.date.issued2003
dc.description.abstractVitamin D intoxication in infancy has serious consequences attributable to acute hypercalcemia and subsequent hypercalcuria/nephrocalcinosis. Current treatments of patients with vitamin D intoxication are unsatisfactory and associated with prolonged hypercalcemia. We now report the use of oral alendronate sodium in a 3-month-old infant with vitamin D intoxication. Short-term oral alendronate sodium treatment effectively corrected hypercalcemia/hypercalciuria, decreased the duration of hospitalization, and appears safe in 15 months of observation.
dc.identifier.doi10.1542/peds.111.4.899
dc.identifier.issn0031-4005
dc.identifier.pubmed12671131
dc.identifier.urihttps://hdl.handle.net/11424/227513
dc.identifier.wosWOS:000181960600030
dc.language.isoeng
dc.publisherAMER ACAD PEDIATRICS
dc.relation.ispartofPEDIATRICS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectbisphosphonates
dc.subjecthypercalcemia
dc.subjecthypervitaminosis D
dc.subjectHYPERCALCEMIA
dc.subjectPAMIDRONATE
dc.subjectCHILDREN
dc.titleOral bisphosphonate therapy for vitamin D intoxication of the infant
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage901
oaire.citation.issue4
oaire.citation.startPage899
oaire.citation.titlePEDIATRICS
oaire.citation.volume111

Files